Folks, et al., "Cytokine Induced Expression of HIV-1 in a Chronically Infected Promonocyte Line," Science, 238:801-802 (1987). |
Castro, et al., "Optimal Conditions for Recovery of the Human Immunodeficiency Virus from Peripheral Blood Mononuclear Cells," J. Clin. Microbiol., 26:2371-2376 (1988). |
Folks, et al., "Characterization of a Promonocyte Clone Chronically Infected With HIV and Inducible By 13-Phorbol 12-Myristate Acetate," J. Immunol, 140:1117-1122 (1988). |
Ho, et al., "Diminished Activity of Protein Kinase C in Tetanus Toxin-Treated Macrophages and in the Spinal Cord of Mice Manifesting Generalized Tetanus Intoxication," J. Infect. Dis., 157:925-933 (1988). |
Jackson, et al., "Rapid and Sensiive Viral Culture Method for Human Immunodeficiency Virus Type 1," J. Clin. Microbiol., 26:1416-18 (1988). |
Coombs, et al., "Plasma Viremia in Human Immunodeficiency Virus Infection," N. Engl. J. Med., 321:1626-1631 (1989). |
Duh, et al., "Tumor Necrosis Factor-.alpha. Activates Human Immuno-deficiency Virus Type-1 Through Induction of Nuclear Factor Binding to the NF-kB Sites in the Long Terminal Repeat," Proc. Natl. Acad. Sci. USA, 86:5974-5978 (1989). |
Harry, et al. "Antigen Detection for Human Immunodeficiency Virus," Clin. Microbiol. Rev. 2:241-260 (1989). |
Ho, et al., "Quantitation of Human Immunodeficiency Virus Type I in the Blood of Infected Persons," N. Engl. J. Med., 321:1621-1625 (1989). |
Osborn, et al. "Tumor Necrosis Factor-.alpha. and Interleukin-1 Stimulate the Human Immunodeficiency Virus Enhancer by Activation of the Nuclear Factor kB," Proc. Natl. Acad. Sci. USA, 86:2336-2340 (1989). |
Poli, et al., "Interferon-.alpha. but Not AZT Suppresses HIV Expression In Chronically Infected Cell Lines," Science, 244:575-577 (1989). |
Schochetman, et al., "Serodiagnosis of Infection With the AIDS Virus and Other Human Retroviruses," Annu. Rev. Microbiol., 43:629-659 (1989). |
Jackson, et al., "Human Immunodeficiency Virus Type 1 Detected in All Seropositive Symptomatic and Asymptomatic Individuals," J. Clin. Microbiol., 28:16-19 (1990). |
Kinter, et al., "Direct and Cytokine-Mediated Activation of Protein Kinase C Induces Immunodeficiency Virus Expression In Chronically Infected Promonocytic Cells," J. Virol., 64:4306-4312 (1990). |
McSharry, et al., "Detection and Quantitation of Human Immunodeficiency Virus-Infected Peripheral Blood Mononuclear Cells by Flow Cytometry," J. Clin. Microbiol., 28:724-733 (1990). |
Moss, A.R., "Laboratory Markers as Potential Surrogates for Clinical Outcomes.," J. Acquired Immune Defic. Syndr., 3(Suppl. 2):S69-S71 (1990). |
Poli, et al. "Tumor Necrosis Factor-.alpha. Functions in an Autocrine Manner in the Induction of Human Immunodeficiency Virus Expression," Proc. Natl. Acad. Sci. USA, 87:782-785 (1990). |
Schreck, et al., "Reactive Oxygen Intermediates As Apparently Widely Used Messengers In the Activation of the NF-kB Transcription Factor and HIV-1," Embo. J., 10:2247-2258 (1991). |
Alimenti, et al., "Diagnois of Vertical Human Immunodeficiency Virus Type 1 Infection By Whole Blood Culture," J. Infect. Dis., 166:1146-1148 (1992). |
Bylung, et al., "Review of Testing For Human Immunodeficiency Virus," Laboratory Immunology II. Clin. Lab. Med., 12:305-333 (1992). |
Mufson, et al., "Phorbol Ester Reduces Constitutive Nuclear NF-kB and Inhibits HIV-1 Production in Mature Human Monocytic Cells," J. Leukocyte Biol., 52:637-644 (1992). |
Poli, et al., "The Effect of Cytokines and Pharmacologic Agents On Chronic HIV Infection," AIDS Res. Hum. Retroviruses, 8:191-197 (1992). |
Schreck, et al. "Antioxidants Selectively Suppress Activation of NF-kB by Human T Cell Leukemia Virus Type I Tax Protein," J. Virol. 66:6288-6293 (1992). |
Butera, et al., "Regulation of HIV-1 Expression by Cytokine Networks in a CD4.sup.+ Model of Chronic Infection," J. Immunol. 150:625-634 (1993). |
Ferre, et al., "Development and Validation of a Polymerase Chain Reaction Method for the Precise Quantitation of HIV-1 DAN in Blood Cells from Subjects Undergoing a 1-year Immunotherapeutic Treatment," AIDS, 7(Suppl. 2):S21-S27 (1993). |
Holzer, et al., "Frequency of Cells Positive for HIV-1 p24 Antigen Assessed By Flow Cytometry," AIDS, 7(supp. 2):S3-S5 (1993). |
Kojima, et al., "Monitoring the Activity of Antiviral Therapy for HIV Infection Using a Polymerase Chain Reaction Method Coupled with Reverse Transcription," AIDS, 7(Suppl. 2):S101-S105 (1993). |
Miles, et al., "Rapid Serologic Testing with Immune-Complex-Dissociated HIV p24 Antigen for Early Detection of HIV Infection in Neonates," N. Engl. J. Med., 328:297-302 (1993). |
Piatak, et al., "High Levels of HIV-1 in Plasma During All Stages of Infection Determined by Competitive PCS," Science, 259:1749-1754 (1993). |
Tetali, et al., "Human Immunodeficiency Virus Type I RNA Detection in Peripheral Blood Mononuclear Cell by Polymerase Chain Reaction: Enhanced Sensitivity after Mitogenic Stimulation," AIDS Res. Hu. Retrovir., 9:77-82 (1993). |
Poli, et al., "Interleukin 1 Induces Expression of the Human Immunodeficiency Virus Alone and in Synergy with Interleukin 6 in Chronicaally Infected U1 Cells: Inhibition of Inductive Effects by Interleukin 1 Receptor Antagonist," Proc. Natl. Acad. Sci. USA, 91:108-112 (1994). |
Ou, et al., "Rapid and Quantitative Detection of Enzymatically Amplified HIV-1 DNA Using Chemiluminescent Oligonucleotide Probes," AIDS Res. Hu. Retrovir., 6:1323-1329 (1990). |
Wei et al., 1995, Nature 373:117-122. |
Ho et al., 1995, Nature 373:123-126. |
Seshamma et al., 1992, J. Virol. Methods 40:331-346. |
Clark et al., 1991, New Engl. J. Med. 324:954-960. |
Daar et al., 1991, New Engl. J. Med. 324:961-964. |
Aldovini and Walker, 1990, Tech, HIV Res. 2:15-29. |
Legrand-Poels et al., 1990, AIDS Res. Hum. Retro. 6:1389-1397. |
Gibco-BRL 1993-94 Life Technologies Catalogue, chapter 1, cell culture reagents and media. |
Coombs et al., 1989, New Engl. J. Med. 321:1626-1631. |